Lyell Immunopharma, Inc. (LYEL) | Jive Data

Google Sheets Add-onSheets Account

Profile Financials SEC Filings Insider Transactions Ownership

Loading LYEL…

Lyell Immunopharma, Inc. (LYEL) | Jive Data

Google Sheets Add-onSheets Account

Profile Financials SEC Filings Insider Transactions Ownership

SEC filing

Lyell Immunopharma, Inc.

LYEL · CIK 1806952

4 · Sep 10, 2026 · Chief Medical Officer Shook David sold 500 shares at $12.70/share ($6,350)

4

Chief Medical Officer Shook David sold 500 shares at $12.70/share ($6,350)

Filed: Sep 10, 2026
Period: Sep 10, 2026
Accession: 0001959742-26-000003
Filer: Lyell Immunopharma, Inc.

View on SEC.gov All SEC filings

Filing document

xslF345X06/form4-09102026_110937.xml

xslF345X06/form4-09102026_110937.xmlSEC.gov

Other files

Graphics and non-inline formats (not embedded below).

4form4-09102026_110937.xml
Open SEC.gov